Today: 20 May 2026
Denison Mines stock slips as uranium tops $100; Phoenix permit decision back in focus
30 January 2026
1 min read

Denison Mines stock slips as uranium tops $100; Phoenix permit decision back in focus

New York, Jan 30, 2026, 11:20 EST — Regular session

Denison Mines Corp’s U.S.-listed shares (DNN) slipped 2.1% to $4.15 in late morning trading Friday, after fluctuating between $4.06 and $4.24. More than 13.5 million shares changed hands.

The recent pullback follows a sharp rally in uranium-linked stocks as spot uranium prices climbed back above triple digits. Yellow Cake’s quarterly update reported the uranium spot price (U3O8, known as “yellowcake”) at $101.25 per pound on Jan. 29, referencing UxC data. CEO Andre Liebenberg noted the market had moved beyond “policy ambition to increased capital deployment.” Investegate

Denison is key in this tape because it’s still waiting on final approvals for its flagship Phoenix project in Saskatchewan. The project is planned as an in-situ recovery (ISR) mine, using wells to circulate a solution through the ore body and pump uranium to the surface. CEO David Cates said the company “stands ready to make a final investment decision” as soon as those approvals come through. Denison Mines Corp.

The stock surged 9.4% on Jan. 28, with around 74 million shares changing hands, before slipping 1.6% on Jan. 29 on roughly 62 million shares, according to historical trading data.

New exploration activity has kicked off around Denison’s territory. On Jan. 28, Cosa Resources announced it began drilling at its Darby project. Drilling at Murphy Lake North is set to start next. Both sites are joint ventures where Cosa operates and owns 70%, with Denison holding the remaining 30%.

Denison followed the weaker trend seen in the major uranium players on Friday. Cameco slipped 5.6%, while Uranium Energy dropped 2.8%, dragging down smaller developers that have surged earlier this month.

The day’s drop didn’t come right after a Denison earnings report or any new company filing. Instead, traders are viewing the stock as a high-beta proxy for uranium prices and nuclear fuel sentiment, which can shift abruptly when the sector loses momentum.

The key risk is timing. Should federal approvals for Phoenix slip into late 2026, the stock could be repriced to reflect a longer delay—especially if uranium prices pull back or appetite for small-cap miners weakens.

Investors are focused on a tight set of factors: the outcome of Cosa’s winter drilling and any upcoming regulatory green light for Phoenix. Denison has indicated that getting approvals by the end of Q1 would clear the way to begin construction and stay on track for first production in mid-2028.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Silver price today: XAG/USD tumbles near $100 as Warsh Fed pick jolts metals
Previous Story

Silver price today: XAG/USD tumbles near $100 as Warsh Fed pick jolts metals

Netflix stock steadies near $83 as Bernstein sticks with $115 target and Warner deal faces new pushback
Next Story

Netflix stock steadies near $83 as Bernstein sticks with $115 target and Warner deal faces new pushback

Go toTop